We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current GENF market cap is 9.97M. The company's latest EPS is GBP -0.0047 and P/E is -6.06.
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 487k | 169k |
| Operating Income | -109k | -459k | -909k | -1.36M |
| Net Income | -109k | -988k | -1.34M | -1.63M |
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 284k | 277k | 2.62M | 1.07M |
| Total Liabilities | 65k | 222k | 251k | 345k |
| Total Equity | 219k | 55k | 2.37M | 726k |
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -73k | -747k | -1.37M | -1.66M |
| Investing | N/A | 199k | -2k | -2k |
| Financing | 327k | 784k | 3.5M | N/A |
| Market Cap | 9.97M |
| Price to Earnings Ratio | -6.06 |
| Price to Sales Ratio | 57 |
| Price to Cash Ratio | 14.25 |
| Price to Book Ratio | 13.73 |
| Dividend Yield | - |
| Shares Outstanding | 349.71M |
| Average Volume (1 week) | 692.02k |
| Average Volume (1 Month) | 1.87M |
| 52 Week Change | -1.72% |
| 52 Week High | 3.30 |
| 52 Week Low | 1.35 |
| Spread (Intraday) | 0.1 (3.45%) |
| Company Name | Genflow Biosciences Plc |
| Address |
6 heddon street london W1B 4BT |
| Website | https://www.genflowbio.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
